INS and type 2 diabetes mellitus: As T2D risk alleles at the IGF2BP2 locus are correlated with reduced islet chromatin accessibility, enhancer activity and IGF2BP2 expression as well as reduced insulin secretion phenotypes24, we hypothesized that reduced activity of IGFBP2 would contribute to a diabetic phenotype in islets.